{"organizations": [], "uuid": "b8bfc215bd71c6a4396db993e54491699e7b1bda", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-knight-therapeutics-says-new-drug/brief-knight-therapeutics-says-new-drug-submission-for-netildex-accepted-for-review-by-health-canada-idUSFWN1Q5168", "country": "US", "domain_rank": 408, "title": "BRIEF-Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T15:54:00.000+02:00", "replies_count": 0, "uuid": "b8bfc215bd71c6a4396db993e54491699e7b1bda"}, "author": "", "url": "https://www.reuters.com/article/brief-knight-therapeutics-says-new-drug/brief-knight-therapeutics-says-new-drug-submission-for-netildex-accepted-for-review-by-health-canada-idUSFWN1Q5168", "ord_in_thread": 0, "title": "BRIEF-Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}], "organizations": [{"name": "brief-knight therapeutics says new drug submiss", "sentiment": "negative"}, {"name": "new drug submission for netildex accepted for review by health canada​ february", "sentiment": "neutral"}, {"name": "netildex accepted for review by health canada​ reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "knight therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 15, 2018 / 1:54 PM / Updated 10 minutes ago BRIEF-Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​ Reuters Staff Feb 15 (Reuters) - Knight Therapeutics Inc: * KNIGHT THERAPEUTICS AND SIFI S.P.A. ANNOUNCE FILING OF NEW DRUG SUBMISSION FOR NETILDEX IN CANADA * KNIGHT THERAPEUTICS INC - ‍KNIGHT‘S NEW DRUG SUBMISSION FOR NETILDEX HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-15T15:54:00.000+02:00", "crawled": "2018-02-15T16:05:35.010+02:00", "highlightTitle": ""}